Signaturefd LLC Sells 947 Shares of The Clorox Company (NYSE:CLX)

Signaturefd LLC lessened its stake in shares of The Clorox Company (NYSE:CLX) by 19.4% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 3,945 shares of the company’s stock after selling 947 shares during the period. Signaturefd LLC’s holdings in Clorox were worth $643,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in Clorox by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after acquiring an additional 48,632 shares in the last quarter. Nuance Investments LLC increased its holdings in Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after buying an additional 960,094 shares during the period. Van ECK Associates Corp raised its stake in Clorox by 1,715.5% in the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after buying an additional 1,380,724 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after buying an additional 120,716 shares during the period. Finally, Acadian Asset Management LLC boosted its position in Clorox by 26.5% during the 1st quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock valued at $135,099,000 after acquiring an additional 184,847 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 0.1 %

Clorox stock opened at $158.92 on Friday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a market cap of $19.74 billion, a PE ratio of 82.34, a PEG ratio of 3.19 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The business’s 50-day simple moving average is $160.25 and its two-hundred day simple moving average is $145.43.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Equities analysts anticipate that The Clorox Company will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Wall Street Analyst Weigh In

CLX has been the subject of several recent research reports. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and boosted their price target for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft increased their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Citigroup boosted their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Six analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Clorox presently has a consensus rating of “Hold” and an average price target of $150.14.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.51% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.